62.00
2.34 (3.92%)
2.34 (3.92%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd | BHVN | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 2.34 | 3.92% | 62.00 | 20:00:00 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 62.00 | 57.70 | 62.19 | 59.71 | 59.66 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,614 | 651,846 | $ 60.17 | $ 39,223,613 | 469,070 | 26.56 - 78.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 21,712 | $ 62.00 | USD |
Biohaven Pharmaceutical Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 3.70B | 59.69M | 43.68M | $ - | $ - | -10.99 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 9.51M | $ - | 0.00% | -266.94k | 9.20% |
Biohaven Pharmaceutical News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BHVN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 63.20 | 65.20 | 57.70 | 62.58 | 462,911 | -1.20 | -1.9% |
| 1 Month | 60.90 | 65.20 | 57.70 | 61.87 | 413,562 | 1.10 | 1.81% |
| 3 Months | 68.77 | 78.75 | 57.66 | 66.41 | 499,749 | -6.77 | -9.84% |
| 6 Months | 29.79 | 78.75 | 28.255 | 55.50 | 738,396 | 32.21 | 108.12% |
| 1 Year | 46.72 | 78.75 | 26.56 | 51.64 | 771,291 | 15.28 | 32.71% |
| 3 Years | 37.13 | 78.75 | 16.5001 | 44.56 | 605,678 | 24.87 | 66.98% |
| 5 Years | 20.00 | 78.75 | 16.5001 | 43.71 | 560,104 | 42.00 | 210.0% |
Biohaven Pharmaceutical Description
| Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV3000-301, BHV3000-302, BHV3000-303, and others. |
